GYRE THERAPEUTICS INC (GYRE)

US4037831033 - Common Stock

10.79  -1.21 (-10.08%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
191.34M113.45M790.00K7.34M20.95M
Minority Interest Expense
-12.60M-7.45MN/AN/AN/A
Cost Of Goods
7.34M4.64M800.00K7.38M9.16M
Gross Profit
183.99M108.81M0.00-40.00K11.79M
Operating Expenses
140.49M89.60M29.41M87.85M68.36M
Research and Development
20.77M13.78M12.44M68.89M52.18M
Selling, General, and Administrative Expenses
118.52M75.82M16.97M18.96M16.18M
Operating Income
43.50M19.21M-29.41M-87.89M-56.57M
Interest Income/Expense
2.03M1.04M540.00K40.00K560.00K
Other Income/Expense
-5.03M-10.78M0.00-80.00K570.00K
Non Recurring Items
N/A-86.44M20.98MN/A-800.00K
Income Before Taxes
-50.75M-76.97M-7.89M-87.93M-56.24M
Income Tax
13.62M8.52M350.00KN/AN/A
Net Income
-76.96M-92.93M-8.24M-87.93M-56.24M
EBITDA
45.66M20.29M-29.21M-87.59M-56.47M
 
Per Share Data
EPS Diluted Total Ops
-0.23-1.41-3.92-43.10-43.93
Non GAAP EPS
N/AN/AN/A-2.87-2.83
 
Statistics
Gross Profit Margin
96.16%95.91%N/A-0.54%56.28%
Profit Margin
-40.22%-81.92%-1043.04%-1197.96%-268.45%
Operating Profit Margin
22.74%16.94%-3722.78%-1197.41%-270.02%

All data in USD

Charts